Search
Close this search box.
Lexogen Successfully Completes Large-Scale Human Primary Cell Next Gen Sequencing Project with Ochre Bio

Lexogen Successfully Completes Large-Scale Human Primary Cell Next Gen Sequencing Project with Ochre Bio

Lexogen-Ochre-Liver_Blog Banner

Vienna, Austria – 25.11.2025 Lexogen, a Vienna-based biotech company specialized in RNA transcriptomics technologies and services announces the completion of a large-scale data generation project producing comprehensive functional genomics datasets from primary human hepatocytes with Ochre Bio. The project included over 120,000 samples assessed with Lexogen’s proprietary extraction-free, high-resolution gene expression profiling platform and NGS Services.

Ochre Bio is a biotechnology company developing RNA medicines for under-treated chronic liver diseases. Ochre builds and integrates extensive human liver data, including proprietary gene perturbation and disease atlases, to make causal pathway predictions for target discovery and facilitate the development of RNA therapies. Ochre’s proprietary OBELiX software enables interrogation of gene biology in human cells, tissue and whole livers, and provides an AI-driven discovery engine for target prioritization.

High-fidelity RNA-Seq data is foundational for Ochre’s human discovery platform. Lexogen NGS Services has been a trusted long-term sequencing partner to Ochre Bio delivering high-quality RNA-Seq data from various sample inputs including bio-banked FFPE to micro-organ and primary hepatocyte samples at scale and in time. Lexogen NGS Services operates in accordance with cGLP and mostly rely on proprietary Lexogen technologies which are designed, developed, and manufactured under ISO 13485 in Vienna, Austria. Their expert teams provide state-of-the-art, streamlined, and customizable workflows to deliver the best results across all sample types, including the most challenging. Lexogen’s proprietary THOR and pooling technologies enable extraction-free RNA-Seq, high consistency and resolution at scale.

About Lexogen

For nearly 20 years, Lexogen offers comprehensive solutions for transcriptome analysis and RNA sequencing, including kits, reagents, bioinformatics, and services (CRO). Lexogen’s products are designed and manufactured in Vienna, Austria, and the sequencing services are also delivered from Vienna. The company is ISO 9001 and 1385 certified, and all services are performed in compliance with cGLP and GDPR.

For more information, visit Lexogen website: www.lexogen.com and follow @lexogen.

Contact:
info@lexogen.com

Phone: +43 1 345 1212

Share This Story, Choose Your Platform!

Related Posts

Cart

Product

Product Short Description
PRICE

Product

Product Short Description
PRICE

Product

Product Short Description
PRICE

My Account

Login

Register